SILO PHARMA, INC. Gains (Losses) on Recourse Debt
SILO PHARMA, INC. (SILO) reported Gains (Losses) on Recourse Debt of $19.08 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRecourseDebt · last filed 2022-03-28
- SILO PHARMA, INC. gains (losses) on recourse debt for the quarter ending 2021-12-31 was $0.00.
- SILO PHARMA, INC. gains (losses) on recourse debt for the quarter ending 2021-09-30 was $0.00.
- SILO PHARMA, INC. gains (losses) on recourse debt for the quarter ending 2021-06-30 was $19.08K.
- SILO PHARMA, INC. gains (losses) on recourse debt for the quarter ending 2021-03-31 was $0.00.
- SILO PHARMA, INC. gains (losses) on recourse debt for fiscal 2021 was $19.08K.
| Period end | Gains (Losses) on Recourse Debt 3 month | Gains (Losses) on Recourse Debt 6 month | Gains (Losses) on Recourse Debt 9 month | Gains (Losses) on Recourse Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $19.08K derived: sum of 3 quarters · filed 2022-03-28 | $19.08K 10-K · filed 2022-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $19.08K derived: sum of 2 quarters · filed 2021-11-10 | $19.08K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $19.08K 10-Q · filed 2021-08-13 | $19.08K 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |